| Product Code: ETC7375978 | Publication Date: Sep 2024 | Updated Date: Oct 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Shubham Padhi | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Grenada Non-Invasive Cancer Diagnostics Market Overview |
3.1 Grenada Country Macro Economic Indicators |
3.2 Grenada Non-Invasive Cancer Diagnostics Market Revenues & Volume, 2021 & 2031F |
3.3 Grenada Non-Invasive Cancer Diagnostics Market - Industry Life Cycle |
3.4 Grenada Non-Invasive Cancer Diagnostics Market - Porter's Five Forces |
3.5 Grenada Non-Invasive Cancer Diagnostics Market Revenues & Volume Share, By Test Type, 2021 & 2031F |
3.6 Grenada Non-Invasive Cancer Diagnostics Market Revenues & Volume Share, By Cancer Type, 2021 & 2031F |
3.7 Grenada Non-Invasive Cancer Diagnostics Market Revenues & Volume Share, By End-user, 2021 & 2031F |
4 Grenada Non-Invasive Cancer Diagnostics Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of cancer in Grenada |
4.2.2 Growing awareness about non-invasive diagnostic techniques |
4.2.3 Technological advancements in the field of cancer diagnostics |
4.3 Market Restraints |
4.3.1 Limited healthcare infrastructure in Grenada |
4.3.2 High cost associated with non-invasive cancer diagnostics |
4.3.3 Lack of skilled healthcare professionals specialized in cancer diagnostics |
5 Grenada Non-Invasive Cancer Diagnostics Market Trends |
6 Grenada Non-Invasive Cancer Diagnostics Market, By Types |
6.1 Grenada Non-Invasive Cancer Diagnostics Market, By Test Type |
6.1.1 Overview and Analysis |
6.1.2 Grenada Non-Invasive Cancer Diagnostics Market Revenues & Volume, By Test Type, 2021- 2031F |
6.1.3 Grenada Non-Invasive Cancer Diagnostics Market Revenues & Volume, By Urine Test, 2021- 2031F |
6.1.4 Grenada Non-Invasive Cancer Diagnostics Market Revenues & Volume, By Imaging Test, 2021- 2031F |
6.1.5 Grenada Non-Invasive Cancer Diagnostics Market Revenues & Volume, By Spectroscopy, 2021- 2031F |
6.2 Grenada Non-Invasive Cancer Diagnostics Market, By Cancer Type |
6.2.1 Overview and Analysis |
6.2.2 Grenada Non-Invasive Cancer Diagnostics Market Revenues & Volume, By Breast Cancer, 2021- 2031F |
6.2.3 Grenada Non-Invasive Cancer Diagnostics Market Revenues & Volume, By Lung Cancer, 2021- 2031F |
6.2.4 Grenada Non-Invasive Cancer Diagnostics Market Revenues & Volume, By Blood Cancer, 2021- 2031F |
6.2.5 Grenada Non-Invasive Cancer Diagnostics Market Revenues & Volume, By Ovarian Cancer, 2021- 2031F |
6.2.6 Grenada Non-Invasive Cancer Diagnostics Market Revenues & Volume, By Colorectal Cancer, 2021- 2031F |
6.2.7 Grenada Non-Invasive Cancer Diagnostics Market Revenues & Volume, By Others, 2021- 2031F |
6.3 Grenada Non-Invasive Cancer Diagnostics Market, By End-user |
6.3.1 Overview and Analysis |
6.3.2 Grenada Non-Invasive Cancer Diagnostics Market Revenues & Volume, By Hospitals & Clinics, 2021- 2031F |
6.3.3 Grenada Non-Invasive Cancer Diagnostics Market Revenues & Volume, By Ambulatory Care, 2021- 2031F |
6.3.4 Grenada Non-Invasive Cancer Diagnostics Market Revenues & Volume, By Others, 2021- 2031F |
7 Grenada Non-Invasive Cancer Diagnostics Market Import-Export Trade Statistics |
7.1 Grenada Non-Invasive Cancer Diagnostics Market Export to Major Countries |
7.2 Grenada Non-Invasive Cancer Diagnostics Market Imports from Major Countries |
8 Grenada Non-Invasive Cancer Diagnostics Market Key Performance Indicators |
8.1 Adoption rate of non-invasive cancer diagnostic technologies in Grenada |
8.2 Number of research and development collaborations for improving cancer diagnostics in Grenada |
8.3 Rate of reimbursement for non-invasive cancer diagnostic procedures in Grenada |
9 Grenada Non-Invasive Cancer Diagnostics Market - Opportunity Assessment |
9.1 Grenada Non-Invasive Cancer Diagnostics Market Opportunity Assessment, By Test Type, 2021 & 2031F |
9.2 Grenada Non-Invasive Cancer Diagnostics Market Opportunity Assessment, By Cancer Type, 2021 & 2031F |
9.3 Grenada Non-Invasive Cancer Diagnostics Market Opportunity Assessment, By End-user, 2021 & 2031F |
10 Grenada Non-Invasive Cancer Diagnostics Market - Competitive Landscape |
10.1 Grenada Non-Invasive Cancer Diagnostics Market Revenue Share, By Companies, 2024 |
10.2 Grenada Non-Invasive Cancer Diagnostics Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here